BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
68.00
+1.20 (1.80%)
At close: Jun 15, 2026, 4:00 PM EDT
69.00
+1.00 (1.47%)
After-hours: Jun 15, 2026, 7:31 PM EDT
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $13.32 billion as of June 15, 2026. Its market cap has increased by 104.79% in one year.
Market Cap
13.32B
Enterprise Value
14.87B
1-Year Change
104.79%
Ranking
Category
Stock Price
$68.00
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $13.32B, an increase of 301.19%. That is a compound annual growth rate of 22.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 13.32B | -9.65% |
| Dec 31, 2025 | 14.74B | 184.24% |
| Dec 31, 2024 | 5.19B | -26.16% |
| Dec 29, 2023 | 7.02B | 516.56% |
| Dec 30, 2022 | 1.14B | -53.61% |
| Dec 31, 2021 | 2.46B | -71.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genmab | 15.40B |
| Jazz Pharmaceuticals | 14.47B |
| Ascendis Pharma | 13.54B |
| Exelixis | 13.35B |
| Axsome Therapeutics | 13.13B |
| Ionis Pharmaceuticals | 12.11B |
| Madrigal Pharmaceuticals | 11.08B |
| Summit Therapeutics | 10.87B |